Penn Medicine Abramson Cancer Center


 

Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immunochemotherapy, LOXO-305, Lisocabtagene Maraleucel

84 views
July 15, 2021
Comments 0
Login to view comments. Click here to Login